張江高科(600895.SH):董事會、監事會延期換屆
格隆匯 12 月 27日丨張江高科(600895.SH)公佈,公司第七屆董事會、第七屆監事會任期於2020年12月28日屆滿。鑑於公司新一屆董事會、監事會相關人選的提名工作尚未完成,公司董事會和監事會將延期換屆,董事會各專門委員會、高級管理人員及董事會聘任的其他人員的任期亦相應順延。
為確保公司相關工作的連續性,在董事會、監事會換屆工作完成之前,公司第七屆董事會、第七屆監事會全體成員、高級管理人員及董事會聘任的其他人員將嚴格依照相關法律、法規和《公司章程》等規定,繼續履行相應的職責和義務。
公司董事會、監事會延期換屆不會影響公司的正常運營。公司將積極推進董事會、監事會的換屆工作,並及時履行相應的信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.